TradingView
warrenhochfeld
Nov 23, 2017 6:54 PM
Aclaris Therapeutics Inc ACRS buy opportunity
Long
NASDAQ:ACRS
240
Aclaris Therapeutics, Inc.
NASDAQ
Description
⋅
Nov 23, 2017 6:54 PM
Buy at a discount ahead of the 24/12/17 PDUFA decision on A-101 in seborrheic keratosis
Trend Analysis
Beyond Technical Analysis
More